Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice:: Characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance

被引:23
作者
Prakash, Chandra
Chen, Weichao
Rossulek, Michelle
Johnson, Kim
Zhang, Chenghong
O'Connell, Thomas
Potchoiba, Michael
Dalvie, Deepak
机构
[1] Pfizer Global Res & Dev, Dept Pharmacokinet, Groton, CT USA
[2] Pfizer Global Res & Dev, Dept Dynam, Groton, CT USA
[3] Pfizer Global Res & Dev, Dept Metab, Groton, CT USA
关键词
D O I
10.1124/dmd.108.022277
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The disposition of torcetrapib {(-)-[2R, 4S] 4-[(3,5-bis-trifluoromethyl-benzyl)methoxycarbonyl-amino-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester}, a cholesteryl ester transfer protein inhibitor, was studied in rats, monkeys, and mice after oral administration of a single dose of [C-14] torcetrapib. Total mean recoveries of the radiocarbon were 90.9, 93.4, and 86.8% from mice, rats, and monkeys, respectively. Excretion of radioactivity was rapid and nearly complete within 48 h after dosing, with a majority excreted in the feces in all species. Torcetrapib was not detected in the urine and/or bile across species, suggesting that it is primarily cleared by metabolism in these species. More than 28 metabolites were identified in all species and were products of oxidation and conjugation pathways. The primary metabolic pathways of torcetrapib involved hydrolysis of the carbamate ester (M2) and the oxidation of the ethyl moieties. M2 was subsequently metabolized in parallel by oxidative cleavage to novel and unusual quinoline metabolites (M3, M4, M5, M9, and M17), M1 (bis trifluoromethyl benzoic acid), and M28 [3,5-bis(trifluoromethyl)-phenyl-(methoxycarbonyl)methanesulfonic acid]. The structures of several metabolites were established by high-resolution liquid chromatography-tandem mass spectrometry and H-1 NMR. The major circulating and excretory metabolites in mice, rats and monkeys were species-dependent; however, several common metabolites were observed in more than one species. In addition to parent torcetrapib, M1, M3, and M4 in rats, M4 and M17 in mice, and M3 and M8 in monkeys were detected as the major circulating metabolites. A mechanism for the formation of an unusual metabolite M28 has been proposed.
引用
收藏
页码:2064 / 2079
页数:16
相关论文
共 29 条
[1]   High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions [J].
Barter, P ;
Kastelein, J ;
Nunn, A ;
Hobbs, R .
ATHEROSCLEROSIS, 2003, 168 (02) :195-211
[2]   Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport [J].
Bruce, C ;
Chouinard, RA ;
Tall, AR .
ANNUAL REVIEW OF NUTRITION, 1998, 18 :297-330
[3]   Metabolism of (R)-(+)-menthofuran in Fischer-344 rats:: Identification of sulfonic acid metabolites [J].
Chen, LJ ;
Lebetkin, EH ;
Burka, LT .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (10) :1208-1213
[4]   Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action [J].
Clark, RW ;
Ruggeri, RB ;
Cunningham, D ;
Bamberger, MJ .
JOURNAL OF LIPID RESEARCH, 2006, 47 (03) :537-552
[5]   Characterization of novel dihydrothienopyridinium and thienopyridinium metabolites of ticlopidine in vitro: Role of peroxidases, cytochromes P450, and monoamine oxidases [J].
Dalvie, DK ;
O'Connell, TN .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (01) :49-57
[6]   Synthesis of the CETP inhibitor torcetrapib: The resolution route and origin of stereoselectivity in the iminium ion cyclization [J].
Damon, David B. ;
Dugger, Robert W. ;
Magnus-Aryitey, George ;
Ruggeri, Roger B. ;
Wester, Ronald T. ;
Tu, Meihua ;
Abramov, Yuriy .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2006, 10 (03) :464-471
[7]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[8]  
EVANS GF, 1994, J LIPID RES, V35, P1634
[9]   INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN-ACTIVITY IN HAMSTERS ALTERS HDL LIPID-COMPOSITION [J].
GAYNOR, BJ ;
SAND, T ;
CLARK, RW ;
AIELLO, RJ ;
BAMBERGER, MJ ;
MOBERLY, JB .
ATHEROSCLEROSIS, 1994, 110 (01) :101-109
[10]   Metabolic aromatization of N-alkyl-1,2,3,4-tetrahydroquinoline substructures to quinolinium by human liver microsomes and horseradish peroxidase [J].
Gu, Chungang ;
Collins, Roxane ;
Holsworth, Daniel D. ;
Walker, Gregory S. ;
Voorman, Richard L. .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (12) :2044-2055